Does THYMOCYTE IMMUNE GLOBULIN NOS Cause Second primary malignancy? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Second primary malignancy have been filed in association with THYMOCYTE IMMUNE GLOBULIN NOS. This represents 0.2% of all adverse event reports for THYMOCYTE IMMUNE GLOBULIN NOS.
13
Reports of Second primary malignancy with THYMOCYTE IMMUNE GLOBULIN NOS
0.2%
of all THYMOCYTE IMMUNE GLOBULIN NOS reports
11
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From THYMOCYTE IMMUNE GLOBULIN NOS?
Of the 13 reports, 11 (84.6%) resulted in death, and 1 (7.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THYMOCYTE IMMUNE GLOBULIN NOS. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does THYMOCYTE IMMUNE GLOBULIN NOS Cause?
Off label use (749)
Drug ineffective (692)
Cytomegalovirus infection (404)
Product use in unapproved indication (396)
Transplant rejection (340)
Post transplant lymphoproliferative disorder (319)
Epstein-barr virus infection (255)
Pneumonia (254)
Multiple organ dysfunction syndrome (250)
Coma (247)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which THYMOCYTE IMMUNE GLOBULIN NOS Alternatives Have Lower Second primary malignancy Risk?
THYMOCYTE IMMUNE GLOBULIN NOS vs THYMOGLOBULINE
THYMOCYTE IMMUNE GLOBULIN NOS vs THYMOL
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROID, PORCINE
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROID, PORCINE\THYROID, UNSPECIFIED
THYMOCYTE IMMUNE GLOBULIN NOS vs THYROTROPIN ALFA